---
title: 可提供女性化激素治疗相关信息的临床指南一览
description: 本文旨在汇总与女性化激素治疗（FHT）有关的诸英语临床指南。
author: Aly
published: 2020-11-20
updated: 2023-05-23
translated: 2023-12-30
translators:
  - Bersella AI
tags:
  - 治疗指南
  - 女性化激素治疗
trackHash: 140e07d414b5b67c93e24a68e50eb9ad2a64c1a6
keywords: [HRT, GAHT, 用药指导, 临床指南]
aliases: /articles/transfem-hormone-guidelines
---

## 摘要 {#abstract}

> 本文将世界上现行的可提供女性化激素治疗相关信息的临床指南加以汇总。其中包括：世界跨性别健康专业协会（WPATH）发表的《跨性别和多元性别人群健康照护指南》；美国内分泌学会发表的《指南》；美国加州大学旧金山分校（UCSF）跨性别健康专家中心发表的《指南》；等等。

## 前言 {#introduction}

医师会引用[临床实践指南][wiki1]（CPG）以学习对不同疾病的照护、并获得相关指引。其中，临床实践指南将特定医学领域的现有科学文献和研究加以回顾和总结；医师毋须考究原始科研文献，便得以安排治疗。尽管[文献评述][wiki2]亦有类似作用，但临床实践指南往往更加翔实，且多基于[循证医学][wiki3]而立，也会定期进行修订。  
制定和维护临床实践指南的有临床医师组织和学会、大学、政府机构，甚至还有大型医院；有的指南是国际/无国界性的，有的则是区域性的。

在跨性别医学方面，已有多份临床实践指南公诸于世（对此加以回顾的有 [Deutsch, Radix, & Reisner, 2016][DRR16]; [Radix, 2019][R19A]; [Radix, 2019][R19B]; [UpToDate][UTD21]; [Bewley et al., 2021][B21]; [Dahlen et al., 2021][D21]; [Ziegler, Carroll, & Charnish, 2021][ZCC21]）。这些指南涵盖心理治疗、激素治疗、声音治疗和适用于跨性别者的外科手术，等等。跨性别临床实践指南不仅起到教育和指导医师的作用，还可为跨性别者所用，帮助其了解所接受的治疗。

本页收录并维护包含世界上已知的、记载女性化激素治疗相关内容的英语临床指南的一份清单。其中，最主要的指南包括：[世界跨性别健康专业协会][wiki4]（WPATH）发表的《[跨性别和多元性别人群健康照护指南][wiki5]》（SOC）<sup>([Coleman et al., 2022][C22])</sup>；[美国内分泌学会][wiki6]发表的《指南》<sup>([Hembree et al., 2017][H17])</sup>；以及美国[加州大学旧金山分校][wiki7]（UCSF）发表的《指南》<sup>([Deutsch, 2016][D16])</sup>。前二者系国际通用，而后者通行于美国。

## 国际性指南 {#international}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| 美国内分泌学会临床实践指南：<br>[用于性别焦虑/性别不一致人群的内分泌治疗][H17] \[[PDF][H17-PDF]]<br> \[另见 [第一版/2009 年修订版][H09]] | Hembree et al.<br>美国内分泌学会 | 2017 | 已出版文章 |
| [跨性别和多元性别人群健康照护指南（第八版）][C22] \*<br>([备用链接][C22-WPATH]; [PDF][C22-PDF])<br>\[另见 [第七版/2012 年修订版][C12] (\[[PDF][C12-PDF]])] | Coleman et al.<br>世界跨性别健康专业协会（WPATH） | 2022 | 已出版文章 |
| [建议对《SOC》第六版修订的内容：用于成人的激素治疗][FS09] | Feldman & Safer | 2009 | 已出版文章 |
| [国际医务咨询小组（IMAP）有关用于跨性别者的激素治疗之立场][IMAP15] \[[PDF][IMAP15-PDF]] | 国际计划生育联合会（IPPF） | 2015 | 线上文档 |
| [对跨性别女性的评估和管理办法][TS23] \*\* \[[PDF][TS23-PDF]] | Tangpricha & Safer<br>UpToDate | 2020 | 线上网页 |

> \* 译者注：《SOC 8》已被翻译为中文，详见 [PDF 文档][C22-ZH-PDF]或[在线网页][C22-ZH]。  
> \*\* 译者注：网页版已于 2023 年 10 月 12 日得到更新。

## 美国地区指南 {#united-states}

| 标题 | 作者/组织［地址］ | 年份 | 形式 |
| --- | --- | --- | --- |
| [用于跨性别和非二元性别人群的初级和性别肯定照护指南][D16] \[[PDF][D16-PDF]] | Deutsch；<br>加州大学旧金山分校（UCSF）跨性别健康专家中心<br> \[加利福尼亚州旧金山市] | 2016 | 线上文档 |
| [对跨性别和多元性别人群的医疗照护][T21] \[[PDF][T21-PDF]] | Thompson, et al.；<br>芬威健康<br> \[马萨诸塞州波士顿市] | 2021 | 线上文档 |
| [激素治疗管理办法][CL18] \[[PDF][CL18-PDF]] | Callen-Lorde 社区健康中心<br> \[纽约州纽约市] | 2018 | 线上文档 |
| [用于性别重置的激素管理办法][D13] | Davidson et al.；<br>Tom Waddell 健康中心；<br>旧金山市公共卫生局<br> \[加利福尼亚州旧金山市] | 2013 | 线上文档 |
| [TransLine 性别肯定激素治疗处方医师指南][G19] \[[PDF][G19-PDF]] | Gorton et al.；<br>TransLine；<br>Lyon-Martin 健康管理服务<br> \[加利福尼亚州旧金山市] | 2019 | 线上文档 |

## 加拿大地区指南 {#canada}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| 初级照护工具箱：<br>[用于 BC 地区跨性别、双重性别和多元性别人群的性别肯定照护][TCBC21] | 不列颠哥伦比亚省跨性别照护服务（Trans Care BC）<br> \[不列颠哥伦比亚省温哥华市] | 2021 | 线上文档 |
| [用于不列颠哥伦比亚省成年跨性别者的内分泌治疗建议性指南][D15]<br>——跨性别内分泌治疗的生理作用 | Dahl et al.；<br>温哥华沿岸健康服务<br> \[不列颠哥伦比亚省温哥华市] | 2015 | 线上文档 |
| [用于跨性别和非二元性别人群的性别肯定初级照护指南][B19] \[[PDF][B19-PDF]] | Bourns；<br>舍邦健康；<br>“安大略彩虹健康”项目<br> \[安大略省多伦多市] | 2019 | 线上文档 |

## 欧洲地区指南 {#europe}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| 欧洲性医学会立场声明：<br>[对青年和成年跨性别者的评估和激素管理办法，附性功能和性满意度相关观点][TS20] | T’Sjoen et al.；<br>欧洲性医学会 | 2020 | 已出版文章 |

## 英国地区指南 {#united-kingdom}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| [良好实践指南：对有性别焦虑的成年人之评估和治疗][W14] \* \[[PDF][W14-PDF]] | Wylie et al.；<br>英国皇家精神医学院 | 2014 | 已出版文章 |
| 各异 \[[PDF][SB17]] \[[PDF][S16]] \[[PDF][LC17]] \[[PDF][T15]] \[[PDF][SD15]] \[[PDF][NHS6] \*\*] | 各异；<br>英国公共卫生服务（NHS）基金机构 | 各异 | 线上文档 |

> \* 译者注：该指南原计划于 2018 年修订，附文“2023 年四月注：已计划适时对本文进行修订”“[该文件并非完全反映本院现行政策](https://www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/college-reports/2011-2013-college-reports)”。  
> \*\* 译者注：原链接不可达，替换为 Archive.org 存档。

## 意大利地区指南 {#italy}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| SIGIS–SIAMS–SIE 联合立场声明：<br>[用于跨性别和非二元性别人群的性别肯定激素治疗][F21] | Fisher et al.；<br>意大利性别、性别认同和性别健康学会  (SIGIS)；<br>意大利男科学和性医学学会 (SIAMS)；<br>意大利内分泌学会 (SIE) | 2021 | 已出版文章 |
| [SIAMS-ONIG 有关用于性身份障碍的激素治疗之共识][G09] | Godano et al.；<br>*意大利男科学和性医学学会* (SIAMS)；<br>*意大利国家性别认同观察中心* (ONIG) | 2009 | 已出版文章 |

## 澳大利亚地区指南 {#australia}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| [有关适用于成年跨性别和多元性别人群的激素管理的立场声明][C19] | Cheung et al. | 2019 | 已出版文章 |
| [澳大利亚照护和治疗指南：用于跨性别和多元性别儿童和青少年群体][T20] \[[PDF][T20-PDF]] | Telfer et al.；<br>澳大利亚皇家儿童医院 | 2020 | 线上文档 |
| [供面向跨性别、多元性别和非二元性别患者的执业医师参考的激素治疗处方指南][C20] \[[PDF][C20-PDF]] | Cundill et al.；<br>Equinox 多元性别健康中心；<br>Thorne Harbour Health | 2020 | 线上文档 |
| [澳大利亚知情同意照护指南：性别肯定激素治疗][APATH22] \[[PDF][APATH22-PDF]] | {{< abbr "AusPATH" >}} | 2022 | 线上文档 |

## 新西兰地区指南 {#new-zealand}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| [用于新西兰多元性别和跨性别儿童、青年和成年人的性别肯定健康照护指南][O18] \[[PDF][O18-PDF]] | Oliphant et al.；<br>怀卡托大学跨性别健康研究实验室 | 2018 | 已出版文章 |

## 南非地区指南 {#south-africa}

| 标题 | 作者/组织 | 年份 | 形式 |
| --- | --- | --- | --- |
| [南非艾滋病医师协会有关性别肯定健康照护的指南，适用于南非][SAHCS21] \[[PDF][SAHCS21-PDF]] | Tomson et al.；<br>南非艾滋病医师协会 (SAHCS) | 2021 | 已出版文章 |

## 其余地区性指南 {#elsewhere}

| 标题 | 作者/组织［地区］ | 年份 | 形式 |
| --- | --- | --- | --- |
| [用于亚太地区跨性别者和跨性别群体的综合照护服务蓝皮书][HPP15] \[[PDF][HPP15-PDF]] | 全球健康政策项目（HPP）；<br>亚太地区跨性别网络；<br>联合国开发计划署<br>\[亚太地区] | 2015 | 线上文档 |
| [用于加勒比地区和其它英语国家的跨性别者及群体的综合照护服务蓝皮书][JS14] \[[PDF][JS14-PDF]] | John Snow, Inc.；<br>泛美卫生组织；<br>世界卫生组织<br>\[拉丁美洲和加勒比地区] | 2014 | 线上文档 |
| [有关性别肯定照护的良好实践指南][SE19] | 萨福性/性别平等组织（Sappho for Equality） \[印度] | 2019 | 线上文档 |
| [IDEA 集体共识：用于寻求女性化性别确认的成年性别不一致个体的医疗管理][M20] | Majumder et al.；<br>糖尿病和内分泌学综合学院 (IDEA) \[印度] | 2020 | 已出版文章 |
| [泰国跨性别健康照护服务手册][V21] \[[PDF][V21-PDF]] | Vacharathit et al.；<br>朱拉隆功大学跨性别健康专家中心 \[泰国] | 2021 | 线上文档 |

## 参考文献 {#references}

- AusPATH. (2022). *Australian Informed Consent Standards of Care for Gender Affirming Hormone Therapy.* Australia: Australian Professional Association for Trans Health. \[[URL][APATH22]] \[[PDF][APATH22-PDF]]
- Bewley, S., Dahlen, S., Connolly, D., Arif, I., Junejo, M., & Catherine, M. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review & Quality Assessment. How Does the Endocrine Society Fare? *Journal of the Endocrine Society*, *5*(Suppl 1), A791–A791. \[DOI:[10.1210/jendso/bvab048.1609][B21]]
- Bourns, A. (2019). *Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition.* Toronto: Rainbow Health Ontario/Sherbourne Health. \[[URL][B19]] \[[PDF][B19-PDF]]
- Callen-Lorde Community Health Center. (2018). *Protocols for the Provision of Hormone Therapy*. New York City: Callen-Lorde Community Health Center. \[[URL][CL18]] \[[PDF][CL18-PDF]]
- Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse Individuals. *Medical Journal of Australia*, *211*(3), 127–133. \[DOI:[10.5694/mja2.50259][C19]]
- Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). \[World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. *International Journal of Transgenderism*, *13*(4), 165–232. \[DOI:[10.1080/15532739.2011.700873][C12]] \[[URL][C22-WPATH]] \[[PDF][C12-PDF]]
- Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). \[World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. *International Journal of Transgender Health*, *23*(Suppl 1), S1–S259. \[DOI:[10.1080/26895269.2022.2100644][C22]] \[[URL][C22-WPATH]] \[[PDF][C22-PDF]] *译者注：已翻译为中文（[在线版][C22-ZH] | [PDF][C22-ZH-PDF]）*
- Cundill, P., Wong, P., Cheung, A., & Brownhill, A. (2020). *Hormone Therapy Prescribing Guide for General Practitioners working with Trans, Gender Diverse and Non-Binary Patients \[Version 3.0].* Australia: Equinox Gender Diverse Health Centre/Thorne Harbour Health. \[[URL][C20]] \[[PDF][C20-PDF]]
- Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2015). *Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy.* Vancouver: Vancouver Coastal Health. \[[Google 学术][D15-GS]] \[[PDF][D15]]
- Dahlen, S., Connolly, D., Arif, I., Junejo, M. H., Bewley, S., & Meads, C. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review and Quality Assessment. *BMJ Open*, *11*(4), e048943. \[DOI:[10.1136/bmjopen-2021-048943][D21]]
- Davidson, A., Franicevich, J., Freeman, M., Lin, R., Martinez, L., Monihan, M., Porch, M., Samuel, L., Stukalin, R., Vormohr, J., & Zevin, B. (2013). *Protocols for Hormonal Reassignment of Gender.* San Francisco: San Francisco Department of Public Health/Tom Waddell Health Center. \[[Google 学术][D13-GS]] \[[PDF][D13]]
- Deutsch, M. B. (Ed.). (2016). *Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition.* San Francisco: University of California, San Francisco/UCSF Transgender Care. \[[URL][D16]] \[[PDF][D16-PDF]]
- Deutsch, M. B., Radix, A., & Reisner, S. (2016). What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care. *AMA Journal of Ethics*, *18*(11), 1098–1106. \[DOI:[10.1001/journalofethics.2016.18.11.stas1-1611][DRR16]]
- Feldman, J., & Safer, J. (2009). Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the *Standards of Care*. *International Journal of Transgenderism*, *11*(3), 146–182. \[DOI:[10.1080/15532730903383757][FS09]]
- Fisher, A. D., Senofonte, G., Cocchetti, C., Guercio, G., Lingiardi, V., Meriggiola, M. C., Mosconi, M., Motta, G., Ristori, J., Speranza, A. M., Pierdominici, M., Maggi, M., Corona, G., & Lombardo, F. (2021). SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. *Journal of Endocrinological Investigation*, *45*(3), 657–673. \[DOI:[10.1007/s40618-021-01694-2][F21]]
- Godano, A., Maggi, M., Jannini, E., Meriggiola, M. C., Ghigo, E., Todarello, O., Lenzi, A., & Manieri, C. (2009). SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity Disorders. *Journal of Endocrinological Investigation*, *32*(10), 857–864. \[DOI:[10.1007/BF03345758][G09]]
- Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). *TransLine Gender Affirming Hormone Therapy Prescriber Guidelines.* San Francisco: Lyon-Martin Health Services/TransLine. \[[URL][G19]] \[[PDF][G19-PDF]]
- Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme. (2015). *Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities.* Washington, DC: Futures Group, Health Policy Project. \[[PDF][HPP15-PDF]]
- Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. *The Journal of Clinical Endocrinology & Metabolism*, *94*(9), 3132–3154. \[DOI:[10.1210/jc.2009-0345][H09]]
- Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. *The Journal of Clinical Endocrinology and Metabolism*, *102*(11), 3869–3903. \[DOI:[10.1210/jc.2017-01658][H17]] \[[PDF][H17-PDF]]
- International Planned Parenthood Federation (IPPF). (2015). *IMAP Statement on Hormone Therapy for Transgender People.* International Medical Advisory Panel/International Planned Parenthood Federation. \[[URL][IMAP15]] \[[PDF][IMAP15-PDF]]
- Latkin, S., & Coakley, G. (2017). *\[Transgender Women] Prescribing Guidelines.* Doncaster/Bassetlaw: Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust. \[[PDF][LC17]] *译者注：原链接不可达，替换为 Archive.org 存档*
- Majumder, A., Chatterjee, S., Maji, D., Roychaudhuri, S., Ghosh, S., Selvan, C., George, B., Kalra, P., Maisnam, I., & Sanyal, D. (2020). IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as Female. *Indian Journal of Endocrinology and Metabolism*, *24*(2), 128–135. \[DOI:[10.4103/ijem.IJEM\_593\_19][M20]]
- Oliphant, J., Veale, J., Macdonald, J., Carroll, R., Johnson, R., Harte, M., Stephenson, C. & Bullock, J. (2018). *Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealand*. Waikato: Transgender Health Research Lab/University of Waikato. \[[URL][O18]] \[[PDF][O18-PDF]]
- Pan American Health Organization, John Snow, Inc., World Professional Association for Transgender Health, et al. (2014). *Blueprint for the Provision of Comprehensive Care for Trans Persons and* *Their Communities in the Caribbean and Other Anglophone Countries.* Arlington: John Snow, Inc. \[[Alt][JS14]] \[[PDF][JS14-PDF]]
- Radix, A. (2019). Hormone Therapy for Transgender Adults. *The Urologic Clinics of North America*, *46*(4), 467–473. \[DOI:[10.1016/j.ucl.2019.07.001][R19A]]
- Radix, A. (2019). Primary Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). *Transgender Medicine: A Multidisciplinary Approach* *(Contemporary Endocrinology)* (pp. 51–67). Cham: Humana Press. \[DOI:[10.1007/978-3-030-05683-4\_4][R19B]]
- Sappho for Equality. (2019). *A Good Practice Guide to Gender-Affirmative Care.* Kolkata: Sappho for Equality. \[[PDF][SE19]]
- Seal, L. J. (2016). *Information About Hormonal Treatment for Trans Women.* London: West London Mental Health NHS Trust/West London NHS Trust. \[[PDF][S16]]
- Seal, L., & Barrett, J. (2017). *Shared Care Prescribing Guidance for Treatment of Gender Dysphoria in Transwomen (Male to Female Transsexuals).* London: West London Mental Health NHS Trust/West London NHS Trust. \[[PDF][SB17]]
- Sullivan, C., & Dean, J. (2015). *Prescribing Guideline. Pharmacological Treatment of Gender Dysphoria.* Devon: Devon Partnership NHS Trust. \[[PDF][SD15]]
- Tangpricha, V., & Safer, J. D. (2020). *Transgender Women: Evaluation and Management.* UpToDate. \[[URL][TS23]] \[[PDF][TS23-PDF]] *译者注：2023 年 10 月已更新*
- Telfer, M. M., Tollit, M. A., Pace, C. C., & Pang, K. C. (2020). *Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents Version 1.2*. Melbourne: The Royal Children’s Hospital. \[[PDF][T20-PDF]]
- Thomas, C. (2015). *Guidelines for the Use of Feminising Hormone Therapy. Information for Primary Care.* Sunderland: City Hospitals Sunderland NHS Trust. \[[PDF][T15]]
- Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). *Medical Care of Trans and Gender Diverse Adults.* Boston: Fenway Health. \[[URL][T21]] \[[PDF][T21-PDF]]
- Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. *Southern African Journal of HIV Medicine*, *22*(1), a1299. \[DOI:[10.4102/sajhivmed.v22i1.1299][SAHCS21]] \[[PDF][SAHCS21-PDF]]
- Trans Care BC. (2021). *Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit.* Vancouver: Provincial Health Services Authority/Trans Care BC. \[[URL][TCBC21-URL]] \[[PDF][TCBC21]]
- T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”. *The Journal of Sexual Medicine*, *17*(4), 570–584. \[DOI:[10.1016/j.jsxm.2020.01.012][TS20]]
- UpToDate. (2021). *Society Guideline Links: Transgender Health.* UpToDate. \[[URL][UTD21]]
- Vacharathit, V., Ratanalert, W., & Samitpol, K. (2021). *The Thai Handbook of Transgender Healthcare Services.* Thailand: Center of Excellence in Transgender Health/Chulalongkorn University. \[[URL][V21]] \[[PDF][V21-PDF]]
- Wilczynski, C., & Emanuele, M. A. (2014). Treating a transgender patient: overview of the guidelines. *Postgraduate Medicine*, *126*(7), 121–128. \[DOI:[10.3810/pgm.2014.11.2840][WE14]]
- Wylie, K., Barrett, J., Besser, M., Bouman, W. P., Bridgman, M., Clayton, A., Green, R., Hamilton, M., Hines, M., Ivbijaro, G., Khoosal, D., Lawrence, A., Lenihan, P., Loewenthal, D., Ralph, D., Reed, T., Stevens, J., Terry, T., Thom, B., Thornton, J., Walsh, D., & Ward, D. (2014). Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria. *Sexual and Relationship Therapy*, *29*(2), 154–214. \[DOI:[10.1080/14681994.2014.883353][W14]]
- Ziegler, E., Carroll, B., & Charnish, E. (2021). Review and Analysis of International Transgender Adult Primary Care Guidelines. *Transgender Health*, *6*(3), 139–147. \[DOI:[10.1089/trgh.2020.0043][ZCC21]]

[wiki1]: https://en.wikipedia.org/wiki/Medical_guideline
[wiki2]: https://en.wikipedia.org/wiki/Literature_review
[wiki3]: https://en.wikipedia.org/wiki/Evidence-based_medicine
[wiki4]: https://en.wikipedia.org/wiki/World_Professional_Association_for_Transgender_Health
[wiki5]: https://en.wikipedia.org/wiki/Standards_of_Care_for_the_Health_of_Transsexual,_Transgender,_and_Gender_Nonconforming_People
[wiki6]: https://en.wikipedia.org/wiki/Endocrine_Society
[wiki7]: https://en.wikipedia.org/wiki/University_of_California,_San_Francisco

[DRR16]: https://dx.doi.org/10.1001/journalofethics.2016.18.11.stas1-1611
[R19A]: https://doi.org/10.1016/j.ucl.2019.07.001
[R19B]: https://doi.org/10.1007/978-3-030-05683-4_4
[UTD21]: https://www.uptodate.com/contents/society-guideline-links-transgender-health
[B21]: https://doi.org/10.1210/jendso/bvab048.1609
[D21]: https://doi.org/10.1136/bmjopen-2021-048943
[ZCC21]: https://doi.org/10.1089/trgh.2020.0043
[C22]: https://doi.org/10.1080/26895269.2022.2100644
[H09]: https://doi.org/10.1210/jc.2009-0345
[D16]: https://transcare.ucsf.edu/guidelines
[H17]: https://doi.org/10.1210/jc.2017-01658
[H17-PDF]: https://academic.oup.com/jcem/article-pdf/102/11/3869/21533864/jc.2017-01658.pdf
[C22-WPATH]: https://www.wpath.org/publications/soc
[C22-PDF]: https://www.tandfonline.com/doi/pdf/10.1080/26895269.2022.2100644
[C22-ZH-PDF]: https://wpath.org/media/cms/Documents/SOC%20v8/Translations/SOC-8-Final_Mandarin.pdf
[C22-ZH]: https://project-trans.org/SOC-8/
[C12]: https://doi.org/10.1080/15532739.2011.700873
[C12-PDF]: https://www.wpath.org/media/cms/Documents/SOC%20v7/Standards%20of%20Care%20V7%20-%202011%20WPATH.pdf
[FS09]: https://doi.org/10.1080/15532730903383757
[IMAP15]: https://www.ippf.org/resource/imap-statement-hormone-therapy-transgender-people
[IMAP15-PDF]: https://www.ippf.org/sites/default/files/ippf_imap_transgender.pdf
[TS23]: https://www.uptodate.com/contents/transgender-women-evaluation-and-management
[TS23-PDF]: https://files.transfemscience.org/pdfs/Tangpricha%20&%20Safer%20%282019%29%20-%20Transgender%20Women_%20Evaluation%20and%20Management%20-%20UpToDate.pdf
[D16-PDF]: https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf
[T21]: https://www.lgbtqiahealtheducation.org/publication/medical-care-of-trans-and-gender-diverse-adults-2021/
[T21-PDF]: https://www.lgbtqiahealtheducation.org/wp-content/uploads/2021/07/Medical-Care-of-Trans-and-Gender-Diverse-Adults-Spring-2021.pdf
[CL18]: https://callen-lorde.org/transhealth/
[CL18-PDF]: https://web.archive.org/web/20221228055728if_/https://callen-lorde.org/graphics/2018/04/Callen-Lorde-TGNC-Hormone-Therapy-Protocols.pdf
[D13]: https://www.sfdph.org/dph/comupg/oservices/medSvs/hlthCtrs/TransGendprotocols122006.pdf
[G19]: https://transline.zendesk.com/hc/en-us/articles/229373288-TransLine-Hormone-Therapy-Prescriber-Guidelines
[G19-PDF]: https://www.transhealthconsulting.com/s/TransLine-HRT-Guidelines-FINAL-9tsd.pdf
[TCBC21]: http://www.phsa.ca/transcarebc/Documents/HealthProf/Primary-Care-Toolkit.pdf
[D15]: http://www.phsa.ca/transcarebc/Documents/HealthProf/BC-Trans-Adult-Endocrine-Guidelines-2015.pdf
[B19]: https://www.rainbowhealthontario.ca/product/4th-edition-sherbournes-guidelines-for-gender-affirming-primary-care-with-trans-and-non-binary-patients/
[B19-PDF]: https://www.rainbowhealthontario.ca/wp-content/uploads/woocommerce_uploads/2019/12/Guidelines-FINAL-Dec-2019-iw2oti.pdf
[TS20]: https://doi.org/10.1016/j.jsxm.2020.01.012
[W14]: https://doi.org/10.1080/14681994.2014.883353
[W14-PDF]: https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/cr181-good-practice-guidelines-for-the-assessment-and-treatment-of-adults-with-gender-dysphoria.pdf
[SB17]: https://web.archive.org/web/20201116155321/https://www.gpref.bedfordshire.nhs.uk/media/160288/Treatment%20of%20Gender_Dysphoria_in_Transwomen_%28Male_to_Female_Transsexuals%29.pdf
[S16]: https://medicines.blmkccg.nhs.uk/wp-content/uploads/2020/05/Treatment-of-Gender-Dysphoria-in-Transwomen-Male-to-Female-Transsexuals-Pt-Information-Leaflet-published-by-West-London-Mental-health-NHS-Trust-Information.pdf
[SD15]: https://web.archive.org/web/20210419204521/https://remedy.bnssgccg.nhs.uk/media/3218/the-laurels-transgender-prescribing-guideline.pdf
[NHS6]: https://web.archive.org/web/20220908114610/https://awttc.nhs.wales/files/guidelines-and-pils/endocrine-management-of-gender-dysphoria-in-adults-pdf/
[F21]: https://doi.org/10.1007/s40618-021-01694-2
[G09]: https://doi.org/10.1007/BF03345758
[C19]: https://doi.org/10.5694/mja2.50259
[T20]: https://www.rch.org.au/adolescent-medicine/gender-service/
[T20-PDF]: https://www.rch.org.au/uploadedFiles/Main/Content/adolescent-medicine/australian-standards-of-care-and-treatment-guidelines-for-trans-and-gender-diverse-children-and-adolescents.pdf
[C20]: https://equinox.org.au/resources/
[C20-PDF]: https://equinoxdotorgdotau.files.wordpress.com/2021/07/ht-prescribing-guideline-v3-aug-2020.pdf
[APATH22]: https://auspath.org.au/2022/03/31/auspath-australian-informed-consent-standards-of-care-for-gender-affirming-hormone-therapy/
[APATH22-PDF]: https://auspath.org.au/wp-content/uploads/2022/03/AusPATH_Informed-Consent-SoC_A4_2022_FINAL.pdf
[O18]: https://researchcommons.waikato.ac.nz/handle/10289/12160
[O18-PDF]: https://researchcommons.waikato.ac.nz/bitstream/handle/10289/12160/Guidelines%20for%20Gender%20Affirming%20Health%20low%20res.pdf
[SAHCS21]: https://doi.org/10.4102/sajhivmed.v22i1.1299
[SAHCS21-PDF]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517808/pdf/HIVMED-22-1299.pdf
[HPP15]: https://www.undp.org/asia-pacific/publications/blueprint-provision-comprehensive-care-trans-people-and-trans-communities-asia-and-pacific
[HPP15-PDF]: https://www.undp.org/sites/g/files/zskgke326/files/migration/asia_pacific_rbap/rbap-hhd-2015-asia-pacific-trans-health-blueprint.pdf
[JS14]: https://iris.paho.org/handle/10665.2/31360
[JS14-PDF]: https://web.archive.org/web/20210419205021/https://www.paho.org/hq/dmdocuments/2014/2014-cha-blueprint-comprehensive-anglo-countries.pdf
[SE19]: http://www.sapphokolkata.in/wp-content/uploads/2019/09/GAT-Revised-Updated_19.09.19.pdf
[M20]: https://doi.org/10.4103/ijem.IJEM_593_19
[V21]: https://ihri.org/transgender-health/
[V21-PDF]: https://ihri.org/wp-content/uploads/2021/09/The-Thai-Handbook-of-Transgender-Heatlhcare-Services.pdf
[B19-PDF]: https://www.rainbowhealthontario.ca/wp-content/uploads/woocommerce_uploads/2019/12/Guidelines-FINAL-4TH-EDITION-n7ozcr.pdf
[C12-PDF]: https://www.wpath.org/media/cms/Documents/SOC%20v7/SOC%20V7_English2012.pdf
[D15-GS]: https://scholar.google.com/scholar?cluster=10288793516023166968
[D13-GS]: https://scholar.google.com/scholar?cluster=3995032054574212445
[G19-PDF]: https://transline.zendesk.com/hc/en-us/article_attachments/360047702053/TransLine_HRT_Guidelines_FINAL.pdf
[LC17]: https://web.archive.org/web/20210920002540/http://medicinesmanagement.doncasterccg.nhs.uk/wp-content/uploads/2018/06/Doncaster-and-Bassetlaw-Transgender-women-prescribing-guidance.pdf
[T15]: https://www.sunderlandccg.nhs.uk/wp-content/uploads/2016/08/SCCG-Gender-Dysphoria-Feminising-Hormones-Dec-2015-DecX2016.pdf
[TCBC21-URL]: http://www.phsa.ca/transcarebc/health-professionals/clinical-resources
[WE14]: https://doi.org/10.3810/pgm.2014.11.2840